Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Harvoni in Chronic Hepatitis C with Advanced Heart Failure or Lung Disease
NCT02858180Phase 4Completed
- Sponsor
- Duke University
- Start
- Dec 2016
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ledipasvir in hepatitis C virus infection, sponsored by Duke University. Started Dec 2016; status: completed.
02
Drugs
ledipasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02858180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02858180.